Black Rock Inc. Agenus Inc Transaction History

Black Rock Inc.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$0.53 - $0.93 $1.58 Million - $2.78 Million	-2,986,906 Reduced 9.27%	29,249,582 $17 Million
Q4 2023 Feb 13, 2024	BUY	$0.63 - $1.14 $2.42 Million - $4.38 Million	3,843,338 Added 13.54%	32,236,488 $26.8 Million
Q3 2023 Nov 13, 2023	BUY	$1.12 - $1.88 $1.36 Million - $2.28 Million	1,213,041 Added 4.46%	28,393,150 $32.1 Million
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $4.88 Million - $7.6 Million	3,724,892 Added 15.88%	27,180,109 $43.5 Million
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $79,451 - $161,642	54,794 Added 0.23%	23,455,217 $35.7 Million
Q4 2022 Feb 13, 2023	BUY	$2.02 - $3.25 $3.71 Million - $5.97 Million	1,838,256 Added 8.53%	23,400,423 $56.2 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $1 Million - $1.6 Million	510,466 Added 2.42%	21,562,167 $44.2 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $4.02 Million - $8.17 Million	3,096,079 Added 17.24%	21,051,701 $40.8 Million
Q1 2022 May 12, 2022	BUY	$2.35 - $3.47 $718,980 - $1.06 Million	305,949 Added 1.73%	17,955,622 $44.2 Million
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $3.12 Million - $6.12 Million	1,066,957 Added 6.43%	17,649,673 $56.8 Million
Q3 2021 Nov 09, 2021	BUY	$4.98 - $6.63 $2.18 Million - $2.9 Million	437,513 Added 2.71%	16,582,716 $87.1 Million
Q2 2021 Aug 11, 2021	BUY	$2.56 - $5.49 $41.3 Million - $88.6 Million	16,145,203 New	16,145,203 $88.6 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.